EUVIMEDEUVIMED entdecken
Crossref

Codelivery of CPT and siPHB1 with GSH/ROS Dual-Responsive Hybrid Nanoparticles Based on a [12]aneN 3 -Derived Lipid for Synergistic Lung Cancer Therapy

Ya-Xuan Liang, Xue-Yi Sun, De-Zhong Xu, Yi-Nan Gao, Quan Tang, Zhong-Lin Lu iD, Yang Liu

ACS Applied Bio Materials · 2024

DOI: 10.1021/acsabm.4c00206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2024. Verfasst von Ya-Xuan Liang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, China. Hauptthemen laut MEDLINE: Camptothecin, Lung Neoplasms, Nanoparticles, Reactive Oxygen Species. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Beijing Normal University, Beijing Municipal Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CamptothecinLung NeoplasmsNanoparticlesReactive Oxygen SpeciesRNA, Small InterferingAnimalsHumansMiceA549 CellsAntineoplastic AgentsBiocompatible MaterialsCell ProliferationCell SurvivalDrug Screening Assays, AntitumorGlutathioneLipidsMaterials TestingMolecular StructureParticle SizeProhibitins

Stichwörter der Autor:innen

[12]aneN3dual-responsivegene/drug codeliverylipid–polymer hybrid nanoparticlessynergistic therapy

Substanzen

Antineoplastic AgentsBiocompatible MaterialsCamptothecinGlutathioneLipidsPHB protein, humanProhibitinsReactive Oxygen SpeciesRNA, Small Interfering

Autor:innen und Institutionen

  • Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, China.
  • China National Institute for Food and Drug Control, Institute of Chemical Drug Control, HuaTuo Road 29, Beijing 100050, China.

ORCID-Profile: Zhong-Lin Lu

Förderung

  • Beijing Normal University
  • Beijing Municipal Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Liang, Y. X., Sun, X. Y., Xu, D. Z., Gao, Y. N., Tang, Q., Lu, Z. L., & Liu, Y. (2024). Codelivery of CPT and siPHB1 with GSH/ROS Dual-Responsive Hybrid Nanoparticles Based on a [12]aneN 3 -Derived Lipid for Synergistic Lung Cancer Therapy. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.4c00206

Vancouver

Liang YX, Sun XY, Xu DZ, Gao YN, Tang Q, Lu ZL, et al. Codelivery of CPT and siPHB1 with GSH/ROS Dual-Responsive Hybrid Nanoparticles Based on a [12]aneN 3 -Derived Lipid for Synergistic Lung Cancer Therapy. ACS Applied Bio Materials. 2024. doi:10.1021/acsabm.4c00206

BibTeX
@article{Liang2024,
  author = {Liang, Ya-Xuan and Sun, Xue-Yi and Xu, De-Zhong and Gao, Yi-Nan and Tang, Quan and Lu, Zhong-Lin and Liu, Yang},
  title = {Codelivery of CPT and siPHB1 with GSH/ROS Dual-Responsive Hybrid Nanoparticles Based on a [12]aneN 3 -Derived Lipid for Synergistic Lung Cancer Therapy},
  journal = {ACS Applied Bio Materials},
  year = {2024},
  doi = {10.1021/acsabm.4c00206}
}
Kostenlos starten →